6-[[(3S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]hexoxy-methylphosphinic acid;(yttrium)

C37H64NO5PY34 — CID 158874070

IUPAC6-[[(3S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]hexoxy-methylphosphinic acid;(yttrium)
SMILESCC[C@H](/C=C/[C@@H](C)[C@H]1CC[C@H]2C3CC=C4C[C@@H](OC(=O)NCCCCCCOP(C)(=O)O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C.[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y]
InChIInChI=1S/C37H64NO5P.34Y/c1-8-28(26(2)3)14-13-27(4)32-17-18-33-31-16-15-29-25-30(19-21-36(29,5)34(31)20-22-37(32,33)6)43-35(39)38-23-11-9-10-12-24-42-44(7,40)41;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/h13-15,26-28,30-34H,8-12,16-25H2,1-7H3,(H,38,39)(H,40,41);;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/b14-13+;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/t27-,28-,30+,31?,32-,33+,34+,36+,37-;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/m1................................../s1
InChIKeyFRVZWRNZYBXTEB-NJVVSWCDSA-N
MW3656.70 g/mol
LogP9.84
Rot. Bonds14

About 6-[[(3S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]hexoxy-methylphosphinic acid;(yttrium)

6-[[(3S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]hexoxy-methylphosphinic acid;(yttrium) (PubChem CID 158874070) has the molecular formula C37H64NO5PY34 and a molecular weight of 3656.70 g/mol. Its IUPAC name is 6-[[(3S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]hexoxy-methylphosphinic acid;(yttrium).

Molecular Properties

Compound Name6-[[(3S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]hexoxy-methylphosphinic acid;(yttrium)
PubChem CID158874070
Molecular FormulaC37H64NO5PY34
Molecular Weight3656.70 g/mol
Exact Mass3656.25
IUPAC Name6-[[(3S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]hexoxy-methylphosphinic acid;(yttrium)
SMILESCC[C@H](/C=C/[C@@H](C)[C@H]1CC[C@H]2C3CC=C4C[C@@H](OC(=O)NCCCCCCOP(C)(=O)O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C.[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y]
InChIInChI=1S/C37H64NO5P.34Y/c1-8-28(26(2)3)14-13-27(4)32-17-18-33-31-16-15-29-25-30(19-21-36(29,5)34(31)20-22-37(32,33)6)43-35(39)38-23-11-9-10-12-24-42-44(7,40)41;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/h13-15,26-28,30-34H,8-12,16-25H2,1-7H3,(H,38,39)(H,40,41);;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/b14-13+;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/t27-,28-,30+,31?,32-,33+,34+,36+,37-;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/m1................................../s1
InChIKeyFRVZWRNZYBXTEB-NJVVSWCDSA-N
XLogP9.84
TPSA84.86 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds14
Heavy Atoms78
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5003656.70
LogP ≤ 59.84
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze 6-[[(3S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]hexoxy-methylphosphinic acid;(yttrium) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-[[(3S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]hexoxy-methylphosphinic acid;(yttrium)?
The IUPAC name of 6-[[(3S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]hexoxy-methylphosphinic acid;(yttrium) (CID 158874070) is 6-[[(3S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]hexoxy-methylphosphinic acid;(yttrium).
What is the SMILES notation for 6-[[(3S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]hexoxy-methylphosphinic acid;(yttrium)?
The canonical SMILES for 6-[[(3S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]hexoxy-methylphosphinic acid;(yttrium) is CC[C@H](/C=C/[C@@H](C)[C@H]1CC[C@H]2C3CC=C4C[C@@H](OC(=O)NCCCCCCOP(C)(=O)O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C.[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].[Y].
What is the InChIKey of 6-[[(3S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]hexoxy-methylphosphinic acid;(yttrium)?
The InChIKey is FRVZWRNZYBXTEB-NJVVSWCDSA-N. The full InChI is InChI=1S/C37H64NO5P.34Y/c1-8-28(26(2)3)14-13-27(4)32-17-18-33-31-16-15-29-25-30(19-21-36(29,5)34(31)20-22-37(32,33)6)43-35(39)38-23-11-9-10-12-24-42-44(7,40)41;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/h13-15,26-28,30-34H,8-12,16-25H2,1-7H3,(H,38,39)(H,40,41);;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/b14-13+;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/t27-,28-,30+,31?,32-,33+,34+,36+,37-;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/m1................................../s1.
What are the key properties of 6-[[(3S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]hexoxy-methylphosphinic acid;(yttrium)?
6-[[(3S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]hexoxy-methylphosphinic acid;(yttrium) has a molecular weight of 3656.70 g/mol, XLogP of 9.84, 14 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[[(3S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]hexoxy-methylphosphinic acid;(yttrium) is sourced from PubChem (CID 158874070), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).